4D pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 106

Employees

  • Latest Deal Type
  • M&A
  • (Upcoming)

  • Financing Rounds
  • 8

  • Investments
  • 6

4D pharma General Information

Description

Developer of microbiome-based therapeutic products intended for the treatment and management of gastrointestinal, respiratory, autoimmune, neurological, oncological, and other disease conditions. The company utilizes proprietary microbiome discovery, bioinformatics, and patient profiling technologies to identify, characterize, develop, and manufacture live bacterial therapeutics, incorporating bacterial strain libraries, mechanism-based candidate selection, microbiome analysis, machine learning-driven patient stratification, clinical development programs, and in-house manufacturing capabilities, enabling biotechnology companies, pharmaceutical developers, healthcare researchers, and clinical organizations to advance microbiome-derived therapies and precision medicine approaches for a broad range of human diseases.

Contact Information

Website
www.4dpharmaplc.com
Formerly Known As
Schosween 18
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 9 Bond Court, Floor 5
  • Leeds LS1 2JZ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Former Stock Listing
FRPRQ
Corporate Office
  • 9 Bond Court, Floor 5
  • Leeds LS1 2JZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

4D pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome-based therapeutic products intended for the treatment and management of gastrointestinal, respir
Biotechnology
Leeds, United Kingdom
106 As of 2021

Cambridge, MA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

4D pharma Competitors (13)

One of 4D pharma’s 13 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Enterome Venture Capital-Backed Paris, France
Seres Therapeutics Formerly VC-backed Cambridge, MA
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 13 competitors. Get the full list »

4D pharma Patents

  • 98

    Total Documents Applications and Grants

  • Total Patents Families

  • 42

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

4D pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022029303-A1 Lyophilisation process Inactive 06-Aug-2020
GB-202002902-D0 Compositions comprising bacterial strains Inactive 28-Feb-2020
JP-2021526684-A How to stratify ibs patients Pending 07-Jun-2018
AU-2019281024-A1 Method for stratifying ibs patients Inactive 07-Jun-2018
CA-3101541-A1 Method for stratifying ibs patients Pending 07-Jun-2018 G16H50/20
To view 4D pharma’s complete patent history, request access »

4D pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

4D pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore 4D pharma‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial

4D pharma Exits (1)

4D pharma’s most recent exit was on 08-Apr-2016 from BIOMAR Microbial Technologies. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
BIOMAR Microbial Technologies 08-Apr-2016 Completed
To view 4D pharma’s complete exits history, request access »

4D pharma Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
4D Pharma Cork Cork, Ireland 2016
The Microbiota Company Leeds, United Kingdom 2014
4D Pharma Research Aberdeen, United Kingdom 2008

4D pharma FAQs

  • When was 4D pharma founded?

    4D pharma was founded in 2008.

  • Where is 4D pharma headquartered?

    4D pharma is headquartered in Leeds, United Kingdom.

  • What is the size of 4D pharma?

    4D pharma has 106 total employees.

  • What industry is 4D pharma in?

    4D pharma’s primary industry is Biotechnology.

  • Is 4D pharma a private or public company?

    4D pharma is a Private company.

  • What is the current valuation of 4D pharma?

    The current valuation of 4D pharma is .

  • What is 4D pharma’s current revenue?

    The current revenue for 4D pharma is .

  • How much funding has 4D pharma raised over time?

    4D pharma has raised $204M.

  • Who are 4D pharma’s investors?

    Oxford Finance has invested in 4D pharma.

  • Who are 4D pharma’s competitors?

    Vedanta Biosciences, Enterome, Seres Therapeutics, Johnson&Johnson Innovative Medicine, and Bristol-Myers Squibb are some of the 13 competitors of 4D pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process